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Abstract 
Background. In clinical settings, the time varying analysis of gait data relies heavily 
on the experience of the individual(s) assessing these data. Though three dimensional 
kinematics are recognised as time varying waveforms (1D), exploratory statistical 
analysis of these data are generally carried out with multiple discrete or 0D dependent 
variables.  In the absence of an a priori 0D hypothesis, clinicians are at risk of making 
type I and II errors in their statistical analyses, which is why subjective analyses of 
these signals in addition to, or in place of statistics are used in clinical settings.  The 
aim of this communication was to determine if vector field waveform statistics were 
capable of providing quantitative corroboration to practically significant difference 
as determined by two clinically trained gait experts.  Methods. The case study was a 
left hemiplegic Cerebral Palsy (GMFCS I) gait patient following a botulinum toxin 
(BoNT-A) injection to their left gastrocnemius muscle. Findings. When comparing 
the subjective assessments between the two testers, they were in agreement with each 
other for 61% of the joint degrees of freedom and phases of motion analysed. For 
tester 1 and tester 2, they were in agreement with the vector-field analysis for 78% 
and 53% of the variables analysed. When the subjective analyses of tester 1 and tester 
2 were pooled together and then compared to the vector-field analysis, they were in 
agreement for 83% of the time varying kinematic variables analysed. Interpretation. 
These outcomes demonstrate that in principle, vector-field statistics corroborates 
with what a team of clinical gait experts would classify as practically meaningful pre- 
versus post time varying kinematic differences. The potential for vector-field 
statistics to be used as a useful clinical tool for the objective analysis of time varying 
clinical gait data is established.  Future research is recommended to assess the 
usefulness of vector-field analyses during the clinical decision making process.  
Key words: kinematics; lower-limb; biomechanics; statistical parametric mapping; SPM  
*Corresponding Author: Dr Cyril Donnelly, The University of Western Australia, Perth, Western 
Australia, 6009. P:+61 8 6488 3919|F: +61 8 6488 1039|e: cyril.donnelly@uwa.edu.au 
 
2 
1.0 Introduction: 
There is little argument that three dimensional joint kinematics and force data are time varying 
(1D) vector waveforms. In clinical settings, the commonplace analysis of time varying clinical 
gait data is subjective, relying heavily on the experience of the individual(s) assessing these 
data.  Though recognised as waveform data, the exploratory statistical analyses of clinical gait 
data are generally carried out using a variety of discrete, zero-dimensional (0D) dependent 
variables (i.e., min, max, mean, etc.) in an attempt to best model the time varying (1D) 
characteristic of these signals.   
When gait waveforms are objectively assessed to determine the efficacy of a treatment in a 
research setting, the statistical analyses of these three dimensional or multi-component vectors 
are generally modelled with 0D variance about fixed means within pre-defined joint degrees 
of freedom and phases of the gait cycle (Ebert et al., 2013).  From a scientific viewpoint, if no 
a prior 0D hypotheses is presented, and the 1D gait waveform is modelled with 0D 
randomness, researchers are predisposed to making regional focus biases in their statistical 
analysis (Pataky et al., 2013) and virtually guaranteed to make type I errors in their assessment 
of discrete (0D) time points within the waveform (Pataky et al., 2016b).  They are also at-risk 
of making type II errors at every other time point within the time series (Pataky et al., 2013).  
This places practical limitations on the type(s) of quantitative analyses a clinician can use to 
formulate reliable clinical assessments on the effectiveness or efficacy of a given treatment or 
intervention.  
Following the development of vector-field analysis for the mapping of human brain activity 
and anatomy (Friston et al., 1995; Friston et al., 2007), these statistics have been validated for 
the assessment of three dimensional, time varying (1D) kinematic and force vectors (Pataky, 
2016a) in research settings. From a research standpoint, the development of vector-field 
statistics for the analysis of clinical gait can also mitigate the probability of making type I and 
II errors in the statistical assessment of time varying gait data (Pataky et al., 2013).  The utility 
of vector-field statistics for the analysis of time varying gait data within clinical gait settings is 
also apparent.  Specifically, vector-field statistics have the potential to assist in the objective 
analysis of these complex signals (i.e., pre- versus post- versus normative), helping to improve 
the inter- and intra- clinician analysis reliability of these data.   
The primary aim of this communication was to compare the subjective analysis of pre- versus 
post- clinical gait data between two trained clinical gait experts and a vector-field statistical 
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method.  We predict vector-field statistics will corroborate with the subjective clinical analysis 
of both clinical gait experts as the statistical methodology considers the within-dataset time 
varying variability in its entirety. A secondary aim of this communication was to conduct an 
exploratory analyses of the same data using a pre- versus post- 0D scalar analysis.  The purpose 
of these analyses are for completeness, and to highlight some potential limitations associated 
with the 0D analysis of clinical gait data in an exploratory type setting.   
 
2.0 Methods: 
A single paediatric participant (4.4 yrs, 121 cm, 26.4 kg) classified as spastic type left 
hemiplegic Cerebral Palsy (GMFCS I) was the case study chosen for these analyses.  A seven 
camera motion capture system operating at 100 Hz (Vicon MX) recorded three dimensional 
(3D) kinematic marker trajectories during walking gait four days prior to and four weeks 
following a single botulinum toxin (BoNT-A) injection to the left gastrocnemius muscle. 
During each testing session, 20 individual trials were recorded at the participant’s self-selected 
walking speed.  
The kinematic marker set and three dimensional lower-limb kinematic modelling procedures, 
which used a Calibrated Anatomical System Technique (CAST) and functional hip and knee 
joint axes and/or centres.  Full modelling procedures have been describe previously (Besier et 
al., 2003).  Aligning with ISB recommendations, the anatomical degrees of freedom for each 
joint were flexion/extension, ab/adduction and internal/external rotation (Besier et al., 2003; 
Ebert et al., 2013).  For simplicity, a condensed clinical gait report, which contained the three 
dimensional kinematics of the left and right hip, knee and ankle separated into their anatomical 
degrees of freedom (n = 18) was used for analyses (figure 1, pane 1).  All data were time 
normalised to 100% stride.   See appendix A for full three dimensional kinematic gait report.   
Three analyses were performed. First, two testers with 11 and 7 years’ experience analysing 
paediatric cerebral palsy gait independently assessed the mean time varying joint kinematics 
of the participant pre- versus post-  BoNT-A injection (Figure 1, pane 1). The testers were 
instructed to report all clinically meaningful kinematic differences within the stance and swing 
phase of the gait cycle.  They were also asked to report when within the normalised gait cycles 
these differences were observed, as well as the direction of these changes.  See Appendix B for 
written instructions provided to testers.   
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Second, statistical parametric mapping (SPM), specifically a Hotelling’s T2 test (α = 0.05) were 
used to assess the three dimensional (i.e., 3-Component) time varying (1D) vectors of the hip, 
knee and ankle joint.  By modelling the hip, knee and ankle as a 3-Component vector, the 
flexion/extension, ab/adduction, internal/external kinematic waveforms, as well as 
collinearities between them are all modelled statistically.  If significant differences were 
observed, the three dimensional time varying (1D) vector was separated into its vector 
components, and analysed as time varying (1D) scalar waveforms.  Conceptually, these 
analyses would be comparable to using a post hoc analysis when a main effect is identified 
with a three factor ANOVA. See appendix C for a two component time varying (1D) vector 
analysis.   
Agreement between both testers and vector-field analysis were assessed throughout the stance 
and swing phase of a stride.  Agreement was operationally defined as when the same pre- versus 
post- kinematic difference was observed, when the observed difference were in the same 
direction and when the timing of this difference were in alignment (≥80% of the observed 
difference). 
Third, the discrete 0D statistical analysis of 18 independent kinematic waveforms pre- versus 
post- BoNT-A injection were performed. To accomplish this, the local minimum and maximum 
of each kinematic waveform within the stance and swing phases of the gait cycle were analysed.  
All 0D scalar variables were analysed using independent sample t-tests (α = 0.05).  As these 
analyses were exploratory in nature without any a pirori hypotheses, protected post-hoc 
adjustments for multiple comparisons were not made.  It should be noted that pre- versus 
normative and post- versus normative vector-field statistical analyses can be performed.  
Additionally, any alpha level can be chosen for these statistical analyses of these waveform 
data (i.e., α = 0.05, 0.01, 0.10). By using random field theory within the vector field statistical 
approach, alpha is protected for the analysis of time varying and three dimensional or n-
Component vector waveforms.   
3.0 Results:  
The time varying (1D) vector analysis of the three dimensional (i.e., 3-Component) vectors for 
the left and right hip, knee and ankle were statistically different pre- versus post- BoNT-A 
injection (Figure 1, pane 2). The time varying (1D) scalar analysis of each joint degree of 
freedom, pre- versus post- BoNT-A injection (Figure 1, pane 3) revealed statistical differences 
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for all but two lower limb joint degrees of freedom.  These include the left hip flexion/extension 
and right ankle plantar/dorsiflexion.   
When comparing the subjective assessments of the two testers, they were in agreement between 
each other for 61% of the joint degrees of freedom and phases of motion assessed (Table 1). 
For tester 1, there was agreement with the vector-field analysis for 78% of the variables 
analysed. For tester 2, they were in agreement with the vector-field analysis for 53% of the 
variables analysed.  When the subjective analyses of tester 1 and tester 2 were pooled together, 
they were in agreement with the vector field analysis for 83% of the time varying kinematic 
variables analysed. This is practically significant as clinical gait reports are generally analysed 
in teams with or two more clinical gait experts.   
For the 0D analysis, only three of the 72 discrete variables assessed did not reported pre- versus 
post- statistical differences (Table 1).   These included left ankle inversion/eversion and right 
ankle plantar/dorsiflexion during stance, and right knee internal/external rotation during swing.  
For 22 of the 36 gait phase and joint degree of freedom combinations analysed, both the local 
minimum and local maximum were significantly different.    
4.0 Discussion: 
Results showed that for over 80% of the lower limb kinematic variables analysed, one of the 
two clinical gait experts’ subjective analyses of these data were in agreement with the SPM 
vector analyses. We feel this is a practically meaningful result as clinical gait case studies are 
generally analysed in teams of two or more gait experts.  We acknowledge that the kinematic 
variables the testers did not agree upon during their analysis may not have translated to 
differences in their clinical interpretation(s)/recommendation(s) of the data.  These results 
simply show vector-field statistics can provide objective, clinically meaningful information for 
the analysis of time varying kinematic data.  We feel this is a meaningful step forward for the 
objective, exploratory analysis of gait data, as clinicians are provided a statistical tool from 
which best practice clinical decision making can be built from.    
Vector-field statistics offers clinicians an objective analysis framework to work from when 
formulating conclusions and/or making clinical decisions from pre- versus post- versus 
normative clinical gait data.  What is interesting to note is that both researchers, and SPM 
reported increases in left ankle dorsi-flexion following the BoNT-A injection, which aligns 
with previous research studies utilising a vector field statistical approach to assess the influence 
of BoNT-A as a clinical treatment for a similar same populations (Nieuwenhuys et al., 2016).  
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However, SPM did not identify the same differences in knee extension kinematics, which have 
been documented previously (Nieuwenhuys et al., 2016).  In addition, for this clinical case 
study, SPM identified statistical difference at the hip, knee and ankle, which were not observed 
previously (Nieuwenhuys et al., 2016).  These results highlight the importance of using an 
exploratory time varying analysis method like vector field statistics, as each case study is 
patient and treatment specific.   
We appreciate that vector field statistics may be initially perceived by some researchers or 
clinicians as a computationally cumbersome or a time expensive analysis tool.  In reality, vector 
field statistics simplifies the analysis of time varying data. Therein, 1D analyses of a time 
varying waveform can be performed in single step versus researchers attempting to pull out 
multiple 0D variables that best characterises the time varying behaviour of the signal.  An 
additional, and underappreciated benefit for using vector field statistics method over a 0D 
statistical approach is that time does not need to be spent consciously deliberating on the 
rational/method(s) to protect, or not protect alpha.   For example, it could be argued that for the 
0D scalar analysis presented in this manuscript, alpha should have been protected for four 
comparisons (i.e., two maximums and two minimums).  Our rational for not protecting alpha 
is that clinical gait analyses are exploratory in nature.  This type of argument is avoided when 
using SPM, as random field theory and the temporal smoothness of the time varying signals 
are used to define and protect alpha.    
As the focus of this communication was to explore vector-field statistics as a clinical gait 
analysis tool, future research is recommended to assess whether this statistical approach may 
alter or influence the clinical decision making for, and/or assessment of, interventions like 
orthopaedic surgery, BoNT-A treatment, casting, etc. In addition, we encourage researchers to 
investigate the utility of vector field statistics for the clinical assessment of joint moments, joint 
power and joint work pre- versus post- intervention(s).   
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Figure 1:  Pane 1 represents the time varying kinematics of the ankle, knee and hip joint 
separated into their anatomical degrees of freedom (flexion/extension, ab/adduction and 
internal/external rotation) pre- versus post-  BoNT-A injection.  Positive values for the hip, 
knee and ankle represent flexion or dorsiflexion (ankle), adduction or inversion (ankle) and 
internal rotation or adduction (ankle).   Pane 2 represents the three component 1D vector 
analysis of the hip, knee and ankle pre- versus post-  BoNT-A injection.  In pane 2, where the 
T2-statistic (blue or red line) is greater than the critical T2-threshold (red dotted line)(α = 0.05), 
a significant pre- versus post- difference related to the BoNT-A injection is observed. It should 
be noted that the t-statistic can be interpreted as an effect size. The further the T2-statistic 
deviates from the critical T2-threshold defined by the experimental alpha level, the larger the 
relative effect.  Pane 3 represents the scalar 1D analysis of the ankle, knee and hip joint 
separated into their anatomical degrees of freedom pre- versus post- BoNT-A injection.  For 
simplicity, regions of statistical difference (α = 0.05) are highlighted in red or blue.  The 
direction of the difference is interpreted from the pre- versus post- kinematic data presented 
within the shaded regions.  For interested readers, the t-statistic and critical t-threshold for the 
scalar 1D analysis of the ankle, knee and hip joint are presented in Figure S4 of the 
supplementary materials.  
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Table 1: Agreement between both testers and SPM through the stance and swing phase of the 
participant’s stride.  Agreement between both testers and SPM was assessed through the 
stance and swing phase of the participant’s stride.  Agreement was operationally defined as 
when the same pre- versus post- kinematic difference was observed, when the observed 
difference was in the same direction and when the timing of this difference was in alignment 
(≥80% of the observed difference).  In addition, for each degree of freedom, local pre- versus 
post- 0D difference (local minima and maxima) during the stance and swing phase of a single 
stride. 
Joint DoF  
(1D or 0D)  
Stance Phase 
Observation  
Swing Phase 
Observation  
L Hip 
Flex/Ext (1D) 
a Tester 1: ↑ flexion 0-20%  
b Tester 2: ↓ flexion 45-55% 
c SPM: ↔ 
a Tester 1: ↔ 
a Tester 2: ↔ 
a SPM: ↔ 
L Hip 
Flex/Ext (0D) 
Max ↑:39.3(4.0)/43.8(3.4); p = 0.001 
Min ↔: 3.0(4.2) /1.2(2.5); p = 0.091 
Max ↑: 49.7(3.9) /51.9(3.1); p = 0.026 
Min ↔: 9.3(6.5) /7.2(4.5); p = 0.241 
L Hip 
Add/Abd (1D) 
a  Tester 1: ↔ 
b Tester 2: ↑ abduction 45-60% 
a  SPM: ↔ 
a  Tester 1: ↑ abduction 60-100%  
a  Tester 2: ↑ abduction 60-100% 
a  SPM: ↑ abduction 60-80% 
L Hip 
Add/Abd (0D) 
Max ↓: 7.2(2.0) /5.9 (1.5); p = 0.026 
Min ↓:-7.8(3.1)/-10.3(3.6); p = 0.028 
Max ↔: 0.2(3.0) /-1.4(2.8); p = 0.093 
Min ↓: -11.4(1.6) /-15.6(2.1); p <0.001 
L Hip Int/Ext 
Rot (1D) 
a  Tester 1: ↑ int. rot 0-60%  
a  Tester 2: ↑ int. rot 0-60% 
a  SPM: ↑ int. rot 0-60%  
a  Tester 1: ↓ ext. rot 60-100%  
a  Tester 2: ↓ ext. rot 60-100% 
a  SPM: ↓ ext. rot 60-95%  
L Hip Int/Ext 
Rot (0D) 
Max ↑: -2.2 /(2.3) /7.2(2.1); p <0.001 
Min ↑: -12.7(2.4) /-3.6(2.1); p <0.001 
Max ↑: -5.3(2.3) /3.0(2.7); p <0.001 
Min ↑: -17.3(2.9) /-9.6(3.8); p <0.001 
L Knee 
Flex/Ext (1D) 
a Tester 1: ↑ flexion 0-40%  
b Tester 2: ↑ flexion 0-5% 
b SPM: ↑ flexion 0-5%  
a Tester 1: ↑ flexion 95-100%  
b Tester 2: ↑ flexion 70-80%  
c SPM: ↔ 
L Knee 
Flex/Ext (0D) 
Max ↔: 34.9(13.2)/33.3(9.5); p= 0.679 
Min  ↑: -1.4(4.1) /6.9(2.0); p <0.001 
Max ↑: 72.6(3.1) /76.1(3.9); p = 0.005 
Min ↑: 1.7(5.8) /9.1(5.9); p <0.001 
L Knee 
Add/Abd (1D) 
a Tester 1: ↑ adduction 50-60%  
b Tester 2: ↔ 
a SPM: ↑ adduction 50-60%  
a Tester 1: ↑ adduction 60-90%  
b Tester 2: ↔ 
a SPM: ↑ adduction 60-70%  
L Knee 
Add/Abd (0D) 
Max ↓ : 1.0(1.4) /0.6(1.5); p = 0.003 
Min  ↑: -7.3(1.8) /-4.1(0.6); p <0.001 
Max ↑: 6.5(4.2) /11.7(4.2); p = 0.002 
Min  ↑: -8.4(3.0) /-3.5(1.0); p <0.001 
L Knee Int/Ext 
Rot (1D) 
a Tester 1: ↑ int. rot 0-60%  
a Tester 2: ↑ int. rot 0-60% 
a SPM: ↑ int. rot 0-60%  
a Tester 1: ↑ int. rot 60-100%  
a Tester 2: ↑ int. rot 60-100%  
a SPM: ↑ int. rot 60-85;95-100%  
L Knee Int/Ext 
Rot (0D) 
Max ↑: 3.4(1.7) /12.2(1.7); p <0.001 
Min  ↑: -8.3(3.5) /2.2(2.4); p <0.001 
Max ↑: 1.3(2.7) /12.3(1.9); p <0.001 
Min  ↑: -7.8(1.9) /0.7(3.7); p <0.001 
L Ankle P/D 
flexion (1D) 
a Tester 1: ↑ D. Flexion  0-60%  
a Tester 2: ↑ D. Flexion  10-40;45-55% 
a SPM: ↑ D. Flexion  0-5%;20-55% 
a Tester 1: ↑ D. Flexion  80-100%  
a Tester 2: ↑ D. Flexion  90-100% 
a SPM: ↑ D. Flexion  80-100%  
13 
 
 
L Ankle P/D 
flexion (0D) 
Max ↑: 9.4(2.9) /20.0(2.8); p <0.001 
Min  ↑:-11.1(2.7) /-3.6(2.7); p <0.001 
Max ↑: 1.1(4.1) /7.2(5.8); p = 0.001 
Min  ↑: -12.6(4.1) /-7.2(3.3); p <0.001 
L Ankle 
Inv/Ever (1D) 
a Tester 1: ↑ inversion 0-20% 
b Tester 2: ↔ 
a SPM:↑ inversion 0-10% 
a Tester 1: ↑ inversion 60-100% 
b Tester 2: ↔ 
c SPM: ↑ inversion at 60% 
L Ankle 
Inv/Ever (0D) 
Max  ↔:23.6(4.4)/24.8(2.6); p = 0.259 
Min  ↔: 5.5(2.4) /6.2(1.6); p = 0.312 
Max ↑: 20.5(5.3) /25.9(2.8); p = 0.001 
Min   ↑: 7.0(4.6) /11.5(4.0); p = 0.002 
L Ankle 
Add/Abd (1D) 
a Tester 1: ↑ abduction 5-60%; 
a Tester 2:↑ abduction 0-60%; 
a SPM:↑ abduction 0-60%; 
a,b Tester 1: ↑ abduction 70-100% 
a Tester 2: ↑ abduction 60-100% 
b SPM: ↑ abduction 70-80% 
L Ankle 
Add/Abd (0D) 
Max ↓: 2.1(4.5) /-4.7(5.5); p <0.001 
Min ↓:-14.3(2.4)/-19.7(1.9);p <0.001 
Max ↓: 2.4(4.5) / -1.2(4.4); p = 0.013 
Min ↓:-11.6(3.1) /-14.9(1.9); p = 0.001 
R Hip 
Flex/Ext (1D) 
 
a Tester 1: ↓ flexion 30-60% 
a Tester 2: ↓ flexion 45-60% 
a SPM: ↓ flexion 40-60% 
a Tester 1: ↓ flexion 60-85% 
b Tester 2: ↔ 
a SPM: ↓ flexion 60-80% 
R Hip 
Flex/Ext (0D) 
 
Max ↔: 48.1(3.3) /49.9(4.6);p= 0.169 
Min ↓: 8.7(3.0) /0.8(2.7); p <0.001 
Max ↔: 55.4(5.0) /55.0(2.7); p = 0.623 
Min ↓:15.7(7.8) /6.4(5.1); p <0.001 
R Hip 
Add/Abd (1D) 
a Tester 1: ↑ adduction 0-60% 
b Tester 2: ↔ 
a SPM: ↑ adduction 5-45% 
a Tester 1: ↓ abduction 60-75%; ↑ 
adduction 75-100% 
b Tester 2: ↔ 
a SPM: ↓ abduction 65-75%; ↑ adduction 
75-100% 
R Hip 
Add/Abd (0D) 
Max ↑: 7.4(1.9)/ 11.9(2.2); p <0.001 
Min  ↑: -6.4(4.0) /-3.8(3.3); p = 0.071 
Max ↑: 0.2(2.6) /4.3(2.4); p <0.001 
Min  ↑:: -12.0(3.0) /-8.0(2.3); p <0.001 
R Hip Int/Ext 
Rot (1D) 
a Tester 1: ↓ ext. rot. 0-60% 
b Tester 2: ↔ 
a SPM: ↓ ext. rot. 10-18;22-60% 
a Tester 1: ↓ ext. rot. 60-90%  
b Tester 2: ↔ 
a SPM: ↓ ext. rot. 75-85% 
R Hip Int/Ext 
Rot (0D) 
Max ↑: -3.0(1.9) /1.9(2.4); p <0.001 
Min ↑:-10.9(1.9) /-8.5(1.7); p <0.001 
Max ↑: -5.8(2.8) /-3.1(1.7); p <0.001 
Min ↑: -14.4(1.8) /-11.6(2.3); p <0.001 
R Knee 
Flex/Ext (1D) 
a Tester 1: ↓ flexion 20-60% 
a Tester 2: ↓ flexion 40-50% 
a SPM: ↓ flexion 40-60% 
a Tester 1: ↓ flexion 60-85% 
b Tester 2: ↔ 
a SPM:↓ flexion 60-65% 
R Knee 
Flex/Ext (0D) 
Max ↓:46.0(13.2)/39.3(8.1);p <0.001 
Min ↓:12.5(2.8) /9.6(3.2); p <0.001 
Max ↓: 80.4(4.3) /77.8(3.2); p <0.001 
Min ↑: 12.2(5.6) /13.2(7.8); p <0.001 
R Knee 
Add/Abd (1D) 
a Tester 1: ↔ 
a Tester 2: ↔ 
b SPM: ↑ adduction 35-60% 
a Tester 1: ↔ 
a Tester 2: ↔ 
a SPM: ↔ 
R Knee 
Add/Abd (0D) 
Max ↔: -1.7(1.6) /-2.0(1.3); p = 0.536 
Min ↑: -6.9(1.5) /-5.4(1.6); p <0.001 
Max ↔: 1.2(3.5) /3.4(3.1); p = 0.057 
Min ↑: -7.2(2.7) /-5.1(2.6); p = 0.037 
R Knee 
Int/Ext Rot 
(1D) 
a Tester 1: ↔ 
a Tester 2: ↔ 
b SPM: ↓ int. rot. 40-50% 
a Tester 1: ↔ 
a Tester 2: ↔ 
a SPM: ↔ 
R Knee 
Int/Ext Rot 
(0D) 
Max ↓: 6.2(3.9)/ 3.4(2.8); p = 0.001 
Min ↔: -6.6(4.5) /-7.0(2.5); p = 0.707 
Max ↔: 0.3(3.1) /0.1(2.6); p = 0.798 
Min ↔:-11.1(3.3) /-10.4(2.5); p = 0.488 
R Ankle P/D 
flex (1D) 
a Tester 1: ↔ 
a Tester 2: ↔ 
a Tester 1: ↓ D. flexion 70-100% 
b Tester 2: ↔ 
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a SPM: ↔ b SPM: ↔ 
R Ankle P/D 
flex (0D) 
Max ↔:19.4(2.6)/20.6(2.1); p = 0.163 
Min ↔: -2.8(6.0) /-3.8(4.9); p = 0.418 
Max ↓: 11.9(3.7) /9.0(3.4); p = 0.011 
Min ↔: -9.0(6.3) /-10.1(3.7); p = 0.468 
R Ankle 
Inv/Evr (1D) 
a Tester 1: ↑ inversion 0-60% 
a Tester 2: ↑ inversion 0-60% 
a SPM: ↑ inversion 0-60% 
a Tester 1: ↑ inversion 60-100% 
a Tester 2: ↑ inversion 60-100% 
b SPM: ↑ inversion 60-65% 
R Ankle 
Inv/Evr (0D) 
Max ↑:16.7(4.2) /24.6(2.4); p <0.001 
Min ↑: 1.1(1.5) / 5.5(1.7); p <0.001 
Max ↑: 13.9(5.5) /21.0(4.8); p <0.001 
Min ↑: 2.3(3.3) /7.7(3.0); p <0.001 
R Ankle 
Add/Abd (1D) 
a Tester 1: ↑ abduction 0-60% 
a Tester 2: ↑ abduction 0-60% 
a SPM: ↑ abduction 0-60% 
a Tester 1: ↑ abduction 60-100% 
a Tester 2: ↑ abduction 60-100% 
a SPM:↑ abduction 60-100% 
R Ankle 
Add/Abd (0D) 
Max ↓: 3.7(4.8) /-4.3(4.7); p <0.001 
Min ↓:-10.5(2.5)/-21.2(1.5);p <0.001 
Max ↓: 5.6(5.3) /-2.7(4.2); p <0.001 
Min ↓: -8.5(2.2) /-17.5(1.6); p <0.001 
1D analyses  
% indicates percentage of stride where difference were observed  
↑ - Increase | ↓ - Decrease | ↔ - No-change  
Letters a, b, c indicates agreement between assessments (testers and SPM scalar statistic).  There is agreement if they possess 
the same letter and disagreement if they possess different letters.    
0D analyses  
Ho: Maxima  Pre = Maxima Post  
Ho: Minima Pre = Minima Post 
↑ - Increase/more| ↓ - Decrease/less | ↔ - No-change 
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Appendix A:  Full gait analysis.  Normative data band used for reference, however vector field 
statistics can be used to compare it to the pre- versus and/or post- kinematic waveform data. 
 
Figure S1: An example of a full kinematic gait assessment.  The time varying kinematics of 
the pelvis segment, hip joint, knee joint, ankle joint and foot segment pre- versus post-  BoNT-
A injection are presented.  The pelvis segment, hip joint, knee joint, ankle joint were separated 
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into their anatomical degrees of freedom (flexion/extension or tilt, ab/adduction or obliquity 
internal/external rotation).  Positive values for the pelvis, hip, knee and ankle represent flexion 
or dorsiflexion (ankle) or anterior tilt (pelvis), adduction or inversion (ankle) or medial 
obliquity (pelvis) and internal rotation or adduction (ankle).  A positive value for the foot 
segment relative to the global coordinate system of pelvis segment or global coordinate system 
of the laboratory is internal rotation or adduction.  
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Appendix B:  Written instructions to clinical gait experts.  
Thank you for participating in this study.   Using your experience as a clinical gait expert, we 
would like you to provide your clinical interpretation of the following case study.  
Case Study 
Patient: 4.4 yo male (121 cm, 26.4 kg) with spastic left hemiplegia (GMFCS I). Patient has no 
history of orthopaedic surgery and was toxin naïve at time of pre- versusintervention 
assessment. 
Intervention: Botulinum toxin (BoNT-A) injection to the left gastrocnemius muscle. 
Testing environment: Gait laboratory  
Procedure: The patient was asked to attend two testing sessions. Four days prior to and four 
weeks following the BoNT-A intervention.  During the testing sessions, the patient was asked 
to walk at their self-selected walking speed along a 20 m walkway.  Three-dimensional (3D) 
motion capture data was recorded from 20 individual trials during each testing session.   
Analyses: The time varying 3D joint kinematics of the left and right hip, knee and ankle were 
calculated and normalised to a single stride for each of the 20 gait trials pre- versus post BoNT-
A injection. Heel-strike and toe-off during the stance phase was defined as when the vertical 
ground reaction force vector was >10 N.  
Instruction 
From the clinical gait report presented in figure 1, we ask that you conduct your analyses within 
the stance and swing phase of the gait cycle. We ask you complete your clinical gait analyses 
as a pre- versus post BoNT-A intervention assessment.  The normative data bands have been 
provided for reference only [comment relative to normative data is not required].  If you 
observe clinically meaningful kinematic differences pre- versus post BoNT-A intervention in 
any of the gait waveforms provided, we ask that you report the direction and timing of these 
observed differences within the table provided (table 1).  Once completed, please return table 
1 to our independent researcher. 
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Figure S2: 3D joint kinematics of the left (blue) and right (right) hip, knee and ankle pre- 
versus post BoNT-A injection. Heel-strike (0% stride) and toe-off (red and blue vertical lines) 
are defined within the figure. The normative data bands in grey are supplied for reference. 
Positive values for the hip, knee and ankle represent flexion or dorsiflexion (ankle), adduction 
or inversion (ankle) and internal rotation or adduction (ankle).   
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Table S1: Clinical gait reporting table. Please provide any clinically meaningful kinematic 
differences pre- versus post BoNT-A intervention (see figure S2 above).  If any pre- versus 
post differences are observed, please report the direction and within the table provided.   
Name of clinical gait expert: 
 
How many years have you been conducting clinical gait assessments?: 
Are you trained as a Medical Doctor, PhD, PhD & MD or other?: 
 
  
   
Joint DoF Stance Phase 
Observation  
Swing Phase 
Observation  
L Hip Flex/Ext  
 
 
L Hip Add/Abd  
 
 
L Hip Int/Ext Rot  
 
 
L Knee Flex/Ext  
 
 
L Knee Add/Abd  
 
 
L Knee Int/Ext Rot   
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L Ankle P/D Flex  
 
 
L Ankle Inv/Ev  
 
 
L Ankle Add/Abd   
 
 
R Hip Flex/Ext 
 
  
R Hip Add/Abd  
 
 
R Hip Int/Ext Rot  
 
 
R Knee Flex/Ext  
 
 
R Knee Add/Abd  
 
 
R Knee Int/Ext Rot  
 
 
R Ankle P/D Flex  
 
 
R Ankle Inv/Ev  
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R Ankle Add/Abd   
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Appendix C: Three and 2-Component time varying vector analyses with T2-statistic and 
critical T2-threshold presented.   
For the assessment of time varying lower limb kinematics, the authors acknowledged a 2-
Component vector analysis may not be as useful as the 3-Component vector analysis or the 1-
Component scalar analyses, which is why these data appear as supplementary materials. We 
did feel it important to show the reader that vector components can be modelled as 1, 2, 3 and 
n-Component vectors, which is extremely important for the kinetic analysis of clinical gait 
populations.  Specifically, these would be useful for the analysis of knee osteoarthritis and 
anterior cruciate ligament populations, which require knee loads to be analysed as combined 
knee loading vectors.  The 2-component vectors for the knee osteoarthritis would be frontal 
(i.e., extension) and sagittal (i.e., adduction) plane knee moments.  For anterior cruciate 
ligament populations, transverse (i.e., internal rotation) and frontal (i.e., abduction) moments 
would be of interest. Researchers and clinician can also use 3, 2 and 1 component analyses as 
a pseudo post-hoc time varying vector test where they can isolate the vector components (n = 
2) or scalar component (n = 1) that explains a three component vector (n = 3) effect.   
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Pane 3
Left Limb (treatment) Right Limb
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Figure S3: Pane 1 represents the time varying kinematics of the ankle, knee and hip joint 
separated into their anatomical degrees of freedom (flexion/extension, ab/adduction and 
internal/external rotation) pre- versus post-  BoNT-A injection.  Positive values for the hip, 
knee and ankle represent flexion or dorsiflexion (ankle), adduction or inversion (ankle) and 
internal rotation or adduction (ankle).   Pane 2 represents the 3-Component time varying vector 
analysis of the hip, knee and ankle pre- versus post-  BoNT-A injection.  Pane 3 represent the 
2-Component time varying vector analyses of the ankle, knee and hip joint.  For each joint the 
vectors between the flexion/extension and internal/external rotation components (XY), 
flexion/extension and ab/adduction components (XZ), and ab/adduction and internal/external 
rotation (YZ) components are presented.  For both the 3-Component time varying vector 
(middle pane) and 2-Component time varying vector analyses (bottom panes), where the T2-
statistic (blue or red line) is greater than the critical T2-threshold (red dotted line)(α = 0.05), a 
significant kinematic difference pre- versus post-  BoNT-A injection is observed. 
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Appendix D: t-statistic and critical t-thresholds for the scalar 1D SPM analysis of the 
ankle, knee and hip joints.   
 
Figure S4: Depiction of the t-statistic and critical t-threshold for the scalar 1D SPM analysis 
of the ankle, knee and hip joint pre- versus post-  BoNT-A injection.  The joints are separated 
into their anatomical degrees of freedom (flexion/extension, ab/adduction and internal/external 
rotation). Positive values for the hip, knee and ankle represent pre- versus post- kinematic 
changes towards flexion or dorsiflexion (ankle), adduction or inversion (ankle) and internal 
rotation or adduction (ankle).  
.  
 
 
